Cargando…
mTOR Signaling Pathway Regulates the Release of Proinflammatory Molecule CCL5 Implicated in the Pathogenesis of Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a complex pervasive neurodevelopmental disorder and neuroinflammation may contribute to the pathogenesis of ASD. However, the exact mechanisms of abnormal release of proinflammatory mediators in ASD remain poorly understood. This study reports elevated plasma levels...
Autores principales: | Wang, Baojiang, Qin, Yueyuan, Wu, Qunyan, Li, Xi, Xie, Dongying, Zhao, Zhongying, Duan, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002353/ https://www.ncbi.nlm.nih.gov/pubmed/35422816 http://dx.doi.org/10.3389/fimmu.2022.818518 |
Ejemplares similares
-
mTOR, a Potential Target to Treat Autism Spectrum Disorder
por: Sato, Atsushi
Publicado: (2016) -
Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
por: Onore, Charity, et al.
Publicado: (2017) -
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
por: Thomas, Shilu Deepa, et al.
Publicado: (2023) -
mTOR-Dependent Spine Dynamics in Autism
por: Chaudry, Shabani, et al.
Publicado: (2022) -
mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity
por: Pagani, Marco, et al.
Publicado: (2021)